Health Care & Life Sciences » Pharmaceuticals | AB Science

AB Science

AB Science S.A.
Stock Exchange Other OTC
EPS
 $0.78
Market Cap
 $206.19 M
Shares Outstanding
 39.55 M
Public Float
 -
AB Science S.A.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 39.55 M
Public Float
 -
AB Science S.A.
Stock Exchange Euronext Paris
EPS
 EUR0.66
Market Cap
 EUR184.17 M
Shares Outstanding
 40.79 M
Public Float
 24.25 M

Profile

Address
3, Avenue George V
Paris Ile-de-France 75008
France
Employees -
Website http://www.ab-science.com
Updated 07/08/2019
AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. It develops pharmaceutical products for the treatment of cancer, neurological, and inflammatory diseases. The firm also engages in the field of veterinary medicine.

Financials

View All
Created with Highcharts 5.0.14AB Science S.A.Net Income. Fiscal year is January-December. All values EUR Thousands.14 61114 61116 11216 11226 71626 71627 69627 69627 12227 12226 06126 06120132014201520162017201805k10k15k20k25k30k
Created with Highcharts 5.0.14AB Science S.A.Sales/Revenue. Fiscal year is January-December. All values EUR Thousands.1 9331 9332 0992 0992 2842 2841 5081 5081 7391 7391 7011 70120132014201520162017201805001000150020002500

Alain Moussy
Chairman, CEO & Scientific Director
Bertrand Dumazy
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.